resources

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

Suven Life Sciences Ltd.

NSE: SUVEN

BSE: 530239

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Research, Analytics & Technology

317.10-2.2 (-0.70%)

8 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Suven Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Sept
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Suven Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018
General8 Jul 2026
Revised Outcome Of The Meeting Of Board Of Directors- Incorporation Of Wholly Owned Subsidiary (WOS) In Singapore
Revised outcome of the meeting of Board of Directors - Incorporation of Wholly owned Subsidiary (WOS) in Singapore
General8 Jul 2026
Incorporation Of Wholly Owned Subsidiary (WOS) In Singapore
Incorporation of Wholly owned Subsidiary (WOS) in Singapore
Change in Management8 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Dr. Vajja Sambasiva Rao effective from January 21, 2027 for a second term of 5(five) years
Allotment of Equity Shares8 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment
Allotment of 18570133 Equity shares of the Company on preferntial basis upon conversion of 18570133 fully paid warrants
Outcome without intimation8 Jul 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Closure of Trading Window
Allotment of ESOP / ESPS22 Jun 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 2,71,970 Equity shares upon exercise of vested options under SLSL ESOP 2020 Scheme
Press Release / Media Release22 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed News release of our company
Press Release / Media Release17 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed News Release of our Company.
Press Release / Media Release16 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed News Release of our company.
Press Release / Media Release12 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed News Release of our company.
Press Release / Media Release4 Jun 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached News Release of our company
General29 May 2026
Rectification Order For Assesment Year 2020-21
Rectification order for Assesment year 2020-21
General19 May 2026
Clarification On Volume Movement Letter
Clarification on Volume Movement Letter
Newspaper Publication14 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Financial Results
Monitoring Agency Report14 May 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for the quarter ended March 31, 2026
General13 May 2026
Grant Of Stock Options
Grant of Stock options
Outcome of Board Meeting13 May 2026
Board Meeting Outcome for Outcome Of Board Meeting Of Suven Life Sciences Limited Held On May 13, 2026
Outcome of Board Meeting of Suven Life Sciences Limited held on May 13, 2026
Press Release / Media Release12 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached News Release of our company

Frequently Asked Questions

Where can I download the annual report of Suven Life Sciences Ltd.?

Annual reports of Suven Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Suven Life Sciences Ltd.?

Quarterly earnings results and presentations of Suven Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Suven Life Sciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Suven Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Suven Life Sciences Ltd.?

Investor presentations and annual day presentations of Suven Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Suven Life Sciences Ltd.?

Corporate announcements and regulatory filings of Suven Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Suven Life Sciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Suven Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Suven Life Sciences Ltd.?

The ISIN (International Securities Identification Number) of Suven Life Sciences Ltd. is INE495B01038. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Suven Life Sciences Ltd. listed?

Suven Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is SUVEN and the BSE code is -.

Where can I find the shareholding pattern of Suven Life Sciences Ltd.?

The quarterly shareholding pattern of Suven Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Suven Life Sciences Ltd. on Sharpely?

Share price data for Suven Life Sciences Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.